Aniseikonia Tests: A Review of Current Measurement Methods

Aniseikonia, a perceptual asymmetry in ocular image size or shape, disrupts binocular vision and stereopsis. Aniseikonia testing is essential for quantifying visual dysfunction and improving prognosis. This review aims to evaluate advances in aniseikonia testing, with emphasis on clinical utility and methodological limitations.

A narrative review was conducted to synthesize evidence on traditional and digital approaches to aniseikonia assessment, with attention to testing principles and clinical applications.

Traditional afocal lens methods have been supplanted by digital innovations like the New Aniseikonia Test (NAT) and Aniseikonia Inspector version 3 (AI3), which enhance precision through patient-specific optical modeling and adaptive psychophysical protocols. These tools enable efficient quantification of global and meridional aniseikonia, with clinical studies linking measurements to retinal pathologies (epiretinal membranes, macular edema) and surgical outcomes (cataract extraction, retinal detachment repair). Clinical applications extend to patients undergoing retinal surgery and those with amblyopia or binocular vision disorders. However, current tests remain constrained by methodological inconsistencies, including variability in stimulus types (e.g., dichoptic shapes vs. red-green filters), testing distances, and scoring criteria, which limit cross-study comparability.

The findings emphasize the importance of aniseikonia tests in clinical practice, which provide valuable insights into visual dysfunction and can aid in predicting treatment outcomes. Future efforts should prioritize the standardization of test parameters (luminance, contrast) and validation in diverse populations, particularly amblyopic and pediatric patients, to refine diagnostic thresholds. Emerging technologies such as tablets and cell phones will facilitate test administration and improve accessibility. Establishing consensus guidelines for clinical interpretation will enhance reliability in diagnosing and managing aniseikonia. By addressing these challenges, next-generation tests can better align theoretical accuracy with practical application, ultimately improving patient outcomes in conditions where binocular vision is compromised.